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ABSTRACT A unique aspect of the interaction of the fungus Cryptococcus neoformans with macrophages is the phenomenon of
nonlyticexocytosis,alsoreferredtoas“vomocytosis”orphagosomeextrusion/expulsion,whichinvolvestheescapeoffungal
cells from the phagocyte with the survival of both cell types. This phenomenon has been observed only in vitro using subjective
andtime-consumingmicroscopictechniques.Inspiteofrecentadvancesinourknowledgeaboutitsmechanisms,amajorques-
tion still remaining is whether this phenomenon also occurs in vivo. In this study, we describe a novel ﬂow cytometric method
that resulted in a substantial gain in throughput for studying phagocytosis and nonlytic exocytosis in vitro and used it to explore
theoccurrenceofthisphenomenoninamousemodelofinfection.Furthermore,wetestedthehypothesisthathostcellphago-
somalpHaffectednonlyticexocytosis.Theadditionoftheweakbasesammoniumchlorideandchloroquineresultedinasigniﬁ-
cantincreaseofnonlyticexocytosisevents,whereasthevacuolarATPaseinhibitorbaﬁlomycinA1hadtheoppositeeffect.Al-
thoughallthreeagentsareknowntoneutralizephagosomalacidity,theirdisparateeffectssuggestthatphagosomalpHisan
important and complex variable in this process. Our experiments established that nonlytic exocytosis occurred in vivo with a
frequency that is possibly much higher than that observed in vitro. These results in turn suggest that nonlytic exocytosis has a
potentialroleinthepathogenesisofcryptococcosis.
IMPORTANCE Cryptococcus neoformans causes disease in people with immune deﬁciencies such as AIDS. Upon infection, C. neo-
formanscellsareingestedbymacrophageimmunecells,whichprovideanicheforsurvivalandreplication.Afteringestion,mac-
rophagescanexpelthefungiwithoutcausingharmtoeithercelltype,aprocessnamednonlyticexocytosis.Todissectthisphe-
nomenon,weevaluateditsdependenceonthepHinsidethemacrophageandaddresseditsoccurrenceduringinfectionofmice.
We developed new techniques using ﬂow cytometry to measure C. neoformans internalization by and nonlytic exocytosis from
macrophages.Neutralizingthephagosomeaciditychangedtherateofnonlyticexocytosis:activityincreasedwiththeweakbases
chloroquineandammoniumchloride,whereasthevacuolarATPaseinhibitorbaﬁlomycinA1causedittodecrease.Experiments
in mice suggested that nonlytic exocytosis occurred during infection with C. neoformans. These results shed new light on the
interaction between C. neoformans and host macrophages.
Received 18 July 2011 Accepted 22 July 2011 Published 9 August 2011
Citation Nicola AM, Robertson EJ, Albuquerque P, Derengowski LS, and Casadevall A. 2011. Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo
and is inﬂuenced by phagosomal pH. mBio 2(4):e00167-11. doi:10.1128/mBio.00167-11.
Editor Françoise Dromer, Institut Pasteur
Copyright © 2011 Nicola et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported
License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Address correspondence to Arturo Casadevall, arturo.casadevall@einstein.yu.edu.
A.M.N. and E.J.R. contributed equally to this work.
C
ryptococcus neoformans is an encapsulated yeast found world-
wide in soil and pigeon excreta (1). It is the etiologic agent of
cryptococcosis, a disease that is most commonly expressed clini-
callyasalife-threateningmeningoencephalitisthatisestimatedto
kill over 600,000 people yearly (2). Infection occurs by inhalation
of fungal particles, which are readily phagocytosed by alveolar
macrophages (3). In rodents, there is strong evidence that the
outcome of cryptococcal infection depends on whether alveolar
macrophages can control fungal replication after ingestion (4, 5).
Moreover, recent studies with 54 C. neoformans isolates obtained
duringaprospectiveclinicalstudy(6)revealedthatinteractionsof
human isolates with J774 murine macrophage-like cells correlate
with the outcome of human cryptococcal meningoencephalitis
(7). During chronic infection, C. neoformans is often found in
macrophage phagosomes, suggesting that C. neoformans is a fac-
ultativeintracellularpathogen(3,8).Studyingtheinteractionbe-
tweenmacrophagesandC.neoformansiscriticaltounderstanding
how cryptococcosis occurs and could lead to the development of
new preventive and therapeutic strategies (9).
Invitroexperimentshavedemonstratedthatsoonafterphago-
cytosis,thephagosomecontainingC.neoformansundergoesacid-
iﬁcation,fusionwithlysosomes,andmaturation(10);thus,unlike
other intracellular pathogens, C. neoformans does not appear to
interfere with phagosome maturation. Formation of this mature
phagolysosome does not lead to death of the pathogen, however;
instead, C. neoformans is able to thrive and multiply inside this
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C. neoformans survives in the harsh phagosomal environment is
thought to involve a combination of powerful antioxidant mech-
anisms along with damage to phagosomal membranes such that,
over time, acidiﬁcation is not maintained (12, 13).
Perhapsthemostintriguinganduniqueaspectofcryptococcal
intracellular pathogenesis is the phenomenon of nonlytic exocy-
tosis, previously referred to as extrusion (14), expulsion (15), or
vomocytosis(16).Assuggestedbythevariousnames,duringnon-
lytic exocytosis C. neoformans can escape from the host cell after
ingestion with survival of both macrophage and fungal cells (14,
15). We have opted to refer to the phenomenon as nonlytic exo-
cytosis (17) because this phrase describes the process without
making any assumptions about mechanism. Nonlytic exocytosis
events take place at least 2 and up to 24 h after phagocytosis and
appear to be largely a pathogen-dictated phenomenon, as inert
beads are not exocytosed (14, 15). However, the relevance of this
phenomenon for cryptococcal pathogenesis remains unclear be-
cause of the technical challenges of in vivo studies.
The interaction between C. neoformans and phagocytes is usu-
ally studied with a combination of light microscopy (14, 15, 18)
and plating for CFU (19), techniques that can be subjective and
time-consuming. Consequently, attempts have been made to de-
velop ﬂow cytometric assays that measure the association and in-
ternalization of C. neoformans and fungal killing by phagocytic
cells (20). These ﬂow cytometric methods provide a signiﬁcant
improvement over manual assays, but they also have limitations.
In this study, we have improved the existing ﬂow cytometric
methodsandusedthisnovelprotocoltostudytheeffectofphago-
some pH modulation on nonlytic exocytosis and explore its oc-
currence in vivo.
RESULTS
Measuring phagocytosis using ﬂow cytometry. To study C. neo-
formans phagocytosis faster and more accurately, we began this
research by attempting to improve previously described ﬂow cy-
tometry methods (20). We optimized the ﬂuorescent labeling of
C.neoformanscellsusingCMFDA(5-chloromethylﬂuoresceindi-
acetate), which forms covalent bonds to intracellular proteins
(21). C. neoformans cells were readily stained with CMFDA
(Fig. 1B). To stain the macrophages, we used DDAO-SE [9-H-
(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl)-succinimidyl es-
ter], which covalently labels intracellular and extracellular pro-
teins (21). The staining resulted in homogeneously positive cells
with median ﬂuorescence intensity more than a thousand times
higher than that of unstained cells (Fig. 1A). Moreover, the cova-
lent binding of CMFDA and DDAO-SE to cellular proteins en-
sured that they could be traced for at least 24 h (see Fig. S1 in the
supplemental material). We next performed control experiments
tovalidatethismethod,whichshowedthatneitherDDAO-SEnor
CMFDAwastoxictothecellsandthattheﬂowcytometricphago-
cytosisassaygaveresultssimilartothoseofthetraditionalmicros-
copy method (Fig. S2).
Using only these two dyes, it was impossible to differentiate
between attached and ingested C. neoformans (see Fig. S3 in the
supplemental material). To solve this issue, we added Uvitex 2B
(Fig. 1D), a membrane-impermeant chitin-binding stain that la-
bels only C. neoformans cells that are not fully engulfed by the
phagocyte(22).Wealsoadded7-AAD(7-amino-actinomycinD),
a nucleic acid probe that is impermeant to live cells but readily
penetrates the disrupted membranes of dead cells to stain their
nuclei (21) (Fig. 1C). As 7-AAD binds to DNA and C. neoformans
cells have 2  107 bp (23) whereas murine cells have 2.5  109 bp
(24), the settings used efﬁciently detected dead macrophages but
did not separate many dead and live C. neoformans cells (Fig. S4).
The addition of these two dyes led to efﬁcient discrimination of
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FIG 1 Flow cytometry analysis of J774 and C. neoformans cells stained with
differentﬂuorescentdyes.J774cellswerestainedwitheitherDDAO-SE(A)or
7-AAD(C),andC.neoformansstrainH99wasstainedwitheitherCMFDA(B)
or Uvitex 2B (D). Unstained controls were included in each assay and are
shown in the left column. The 7-AAD-stained J774 cells had been previously
ﬁxed with 1% paraformaldehyde and permeabilized with 0.1% saponin to
mimic dead cells. This experiment was repeated at least twice with similar
results.
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macrophages (Fig. 2).
Nonlyticexocytosismeasurementbyﬂowcytometry.Wede-
vised a method to measure the rate of C. neoformans nonlytic
exocytosis from host phagosomes using the ﬂow cytometry tech-
niques described above (Fig. 3). A ﬂuorescence-activated cell
sorter was used to separate events that were positive for CMFDA
and DDAO-SE but negative for Uvitex 2B and 7-AAD, corre-
spondingtolivemacrophagescontainingingestedC.neoformans.
After 24 h, these cells were analyzed again to measure the propor-
tion of macrophages that were no longer associated with C. neo-
formans but were still alive (positive for DDAO-SE
and negative for CMFDA and 7-AAD), corre-
sponding to macrophages that had exocytosed the
internalizedC.neoformans.Thesortingstepdrasti-
callyincreasedsamplepurity,asdeﬁnedbytheper-
centage of macrophages containing internalized
C. neoformans. In the presort samples, this corre-
sponded on average to 42.7% of the total macro-
phages, whereas postsort purity increased to an av-
erage of 91.0% (Fig. 4A). The postsort purity
percentagewasthensubtractedfromtheﬁnalanal-
ysis, so that macrophages that were empty at the
start of the 24-h incubation were not taken into
consideration in the ﬁnal results.
Valuesobtainedforthenonlyticexocytosisrates
measured by ﬂow cytometry ranged from 16.3% to
58.1%,andcombinednumbersresultedinanaver-
age nonlytic exocytosis rate of 29.0% (Fig. 4B). We
compared these numbers to those obtained from
three independent time-lapse microscopy experi-
ments that used the same conditions (J774 cells,
C. neoformans strain H99, and antibody opsoniza-
tion). The nonlytic exocytosis rates measured by
ﬂow cytometry were consistently higher than those
obtained from our microscopy study (12.6%) and
thosereportedbyVoelzetal.(25)(18.3%)butwere
comparable to the rate of 26.7% obtained by Alva-
rez and Casadevall (14). We also noted a difference
in the rates of macrophage lysis when comparing
theﬂowcytometryandmicroscopymeasurements.
Only 1 of the 477 macrophages analyzed in three
microscopy movies had lysed, whereas in the 24-h
ﬂow cytometry samples an average of 27.3% of the
J774 cells were dead as inferred from being 7-AAD
positive (ranging from 4.8% to 46.7%). This large
difference is probably an artifact of the harsh con-
ditions to which the cells are subjected during de-
tachment from plates and sorting.
Tovalidatetheﬂowcytometrymethodology,we
carried out a series of additional experiments. To
exclude the alternative explanation that the events
that we interpreted as nonlytic exocytosis actually
correspondtomacrophagesthatdigestedtheinter-
nalized C. neoformans, we infected murine bone
marrow-derived macrophages (BMM) with heat-
killedfungiandsortedlivemacrophagescontaining
internalized C. neoformans. After 24 h, the cells
were analyzed again and 75% of the sorted macro-
phages remained CMFDA positive (see Fig. S5A in
the supplemental material). Thus, even the extreme and highly
doubtful situation in which the stained C. neoformans cells are
dead and fully exposed to the phagolysosome for 24 h does not
lead to complete loss of CMFDA ﬂuorescence, observed in Fig. 3.
Thisexperimentalsoallowedustocomparethenonlyticexocyto-
sis rates of dead C. neoformans and of live fungi. Once again con-
ﬁrming previous results using live imaging (14, 15), macrophages
exocytosed dead C. neoformans cells less frequently than they did
live ones (Fig. S5B). Another issue that we dealt with is that the
ﬂow cytometry assay does not differentiate nonlytic exocytosis
from macrophage cell division, which can result in a DDAO-SE-
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FIG 2 Flow cytometry phagocytosis assay. (A) Flow cytometric analysis of phagocytosis
after2ho fcoincubation. (B) Diagrammatic representation of the plots in panel A. C. neo-
formansandJ774cellswerestainedwithCMFDA(green)andDDAO-SE(red),respectively;
phagocytosed for 2 h; and stained with Uvitex 2B (blue) and 7-AAD (orange) prior to ﬂow
cytometry.Thedensityplotontheleftshowsmacrophages(i),macrophagesassociatedwith
C. neoformans (ii), debris (iii), and C. neoformans cells (iv). Events in the double-positive
gate(highlightedinred)wereplottedforUvitex2Band7-AADﬂuorescenceintensity(right
plot) to identify internalized C. neoformans and determine phagocyte viability. Three pop-
ulations are distinguishable: (a) Uvitex 2B-negative, 7-AAD-negative, live macrophages
with internalized C. neoformans; (b) 7-AAD-positive, dead phagocytes; and (c) Uvitex 2B-
positive, 7-AAD-negative, live phagocytes with attached C. neoformans. This experiment
wasrepeatedatleast10timeswithsimilarresults.NotethattherightplotinpanelAdoesnot
have a clearly deﬁned 7-AAD-positive, Uvitex 2B-negative population. This is not a com-
pensation artifact (see Fig. S8 in the supplemental material) but is due to the fact that the
membrane rupture of dead macrophages that permits penetration of 7-AAD also permits
penetration of Uvitex 2B, which then labels internalized in addition to attached C. neofor-
mans.
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® mbio.asm.org 3positive/CMFDA-negative/7-AAD-negative daughter cell. As cel-
lular division dilutes DDAO-SE between the two daughter cells,
wereanalyzedtheﬁveﬂowcytometryexperimentsusingJ774cells
and four experiments using BMM, which are less likely to divide
thanareJ774cells(26,27).TheDDAO-SEmedianﬂuorescencein
both cell types decreased in the 24 h between sorting and analysis
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FIG3 Quantiﬁcationofnonlyticexocytosisusingﬂowcytometry.Stainedcellswereallowedtophagocytosefor2handanalyzedinthreestepsofﬂowcytometry
to determine nonlytic exocytosis rates. (A) Events to be sorted were gated for forward and side scatter followed by gating as positive for CMFDA and DDAO-SE
(highlighted in red) and negative for Uvitex 2B and 7-AAD. (B) Cells immediately postsorting, demonstrating enrichment of macrophages with internalized
C. neoformans (gate). (C) Sorted cells were incubated for 24 h and analyzed again. Nonlytic exocytosis events were deﬁned by gating as DDAO-SE positive
(highlighted in red) and CMFDA negative, 7-AAD negative. This experiment was repeated at least 10 times with similar results.
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FIG 4 Comparison between microscopic and ﬂow cytometric measurements of nonlytic exocytosis. (A) Percentage of macrophages that have internalized
C.neoformanscells(DDAO-SEpositive/CMFDApositive/Uvitex2BnegativedividedbytotalDDAO-SEpositive)priortoandimmediatelyaftersorting.Results
arefromﬁveindependentexperimentsdoneondifferentdays.(B)Distributionofpercentnonlyticexocytosismeasuredineachindividualreplicatebytime-lapse
imaging and ﬂow cytometry. The numbers in parentheses represent the macrophages that exocytosed and the total number of macrophages observed when all
replicates were pooled. Data in the last two columns come from previously published results using time-lapse microscopy (14, 25) and have been replotted for
comparison with the ﬂow cytometry method. The results reported by Voelz et al. reﬂect nonlytic exocytosis measured for 20 h in serum-free medium, whereas
all other experiments were done in serum-containing medium for 24 h. Bars represent means; each condition was tested at least three times on different days.
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decreasewasfarmoreintenseinJ774cells.Wethenmeasuredthe
rates of nonlytic exocytosis not only in the entire macrophage
population but also separately on those with DDAO-SE ﬂuores-
cence that was similar to the ﬂuorescence of the postsort cells
(DDAO-SE-high). As shown in Fig. S6B, the nonlytic exocytosis
rate in this population is lower when compared with the entire
macrophage population in J774 cells than when compared with
the entire macrophage population in BMM, indicating that in-
deedsomeoftheeventscountedasexocytosisarereallygenerated
bymacrophagedivision.Moreover,thenonlyticexocytosisratein
DDAO-SE-high J774 cells was remarkably close to that observed
with BMM.
PhagosomalpH-modifyingdrugsaffectnonlyticexocytosis.
We applied the ﬂow cytometry method to study any effects that
drugs that neutralize the macrophage phagosomal pH may have
on nonlytic exocytosis. To achieve this, we measured nonlytic ex-
ocytosisratesofJ774cellsinfectedwithC.neoformansinthepres-
enceofthevacuolarATPase(V-ATPase)inhibitorbaﬁlomycinA1
and the weak bases chloroquine and ammonium chloride. Treat-
ment with baﬁlomycin A1 slightly decreased the rate of nonlytic
exocytosis from 24.7% to 22.5% (P  0.0001), whereas the addi-
tion of ammonium chloride and chloroquine signiﬁcantly in-
creased these rates to 29.4% and 48.1%, respectively (Table 1).
Theincreasecausedbychloroquineisinlinewithpreviouslypub-
lished data, whereas the effects of baﬁlomycin A1 are similar to
those observed with the analogous V-ATPase inhibitor concana-
mycin A (15). As the effect of ammonium chloride on nonlytic
exocytosis rates has never been described, we also quantiﬁed it
using time-lapse microscopy. With the addition of ammonium
chloride,nonlyticexocytosisratesincreasedfrom12.6%to15.9%,
conﬁrmingwhatweobservedwithﬂowcytometry.Duetothelow
number of nonlytic exocytosis events observed, however, the
change was not statistically signiﬁcant (P  0.15).
Nonlytic exocytosis occurs in vivo. We next adapted the ﬂow
cytometry method to address the question of whether the phe-
nomenon of nonlytic exocytosis occurs during infection. The ra-
tionale,outlinedinFig.S7inthesupplementalmaterial,wassim-
ilar,beginningbysortingprimarymurinemacrophagesthatwere
alive and had internalized C. neoformans in vitro. In addition to
being incubated in tissue culture (Fig. 5A), the cells were injected
into a recipient mouse’s lungs and harvested 24 h later. Analyzing
the harvested bronchoalveolar lavage samples, we observed that
morethan99.9%oftheeventswereDDAO-SE-negative(Fig.5B)
recipient mouse cells. A small percentage of DDAO-SE-positive
events was also present in control samples from mice that were
injected with unstained macrophages and C. neoformans cells
(Fig.5C),probablycorrespondingtoparticleswithhighautoﬂuo-
rescence. Careful examination of the unstained control plots,
however, showed that the events that appeared to be DDAO-SE
positiveinthecontrolsamplewerealsostronglyﬂuorescentinthe
7-AAD channel and not present in the in vitro sample, suggesting
that these 7-AAD-high events were false positives. An additional
gate was then set that included over 99% of the true DDAO-SE-
positive macrophages, as measured in the in vitro sample, but
excluded 70 to 85% of the false-DDAO-SE-positive unstained
host cells, as measured in the control sample. Comparing the re-
sults from the in vitro and in vivo experiments showed that non-
lytic exocytosis occurred at higher rates in mouse lungs (44.83%)
than in tissue culture (9.55%) (Table 2).
DISCUSSION
The outcome of the interaction between host macrophages and
C.neoformansisakeyeventindeterminingthefateofinfection(4,
5). Ingestion of C. neoformans by macrophages may lead to either
inhibition or killing of the fungal cell, pathogen replication with
eventual lysis of the host cell, or nonlytic release from the phago-
cyte, after which both cell types remain alive. Nonlytic exocytosis
is a unique strategy for escaping phagocytic cells that may have
haditsoriginasamechanismforfungalsurvivalafteringestionby
amoebae(17).Thisphenomenonhasthusfarbeenstudiedonlyin
vitro, and its physiological relevance is uncertain. Furthermore,
the effects of phagosomal pH on nonlytic exocytosis remain
poorly understood (15). Consequently, we set out to determine
the phagosomal pH effects on the rate of nonlytic exocytosis and
exploredwhetherithappensinvivo.Toachievethis,wedeveloped
a ﬂow cytometric methodology that quantiﬁes phagocytosis and
nonlytic exocytosis with high throughput.
Staining of the C. neoformans cells with two different ﬂuores-
cein derivatives followed by ﬂow cytometry was used by Chaka
and colleagues to study phagocytosis (20). However, those meth-
ods have limitations, including being unsuitable for experiments
lasting more than 3 h and not addressing phagocyte viability. By
bindingcovalentlytothecells,CMFDAandDDAO-SEpermitted
studies with actively dividing cells that lasted more than 24 h.
Other parameters of the interaction were then addressed using
Uvitex 2B and 7-AAD. As seen in Fig. 1, 2, 3, and 5 and in Fig. S5,
S8, and S9, all of which depict independent experiments, there
were differences in ﬂuorescence intensity and population mor-
phology, but overall the patterns were reproducible and resulted
in a method that is more complete and versatile.
In addition to enabling more efﬁcient measurement of phago-
cytosis, the methods that we developed dramatically improved
our ability to measure nonlytic exocytosis. To date, the quantiﬁ-
TABLE 1 Effect of pH-neutralizing compounds on nonlytic exocytosis
rates
Method and treatment (concn)
No. of
macrophagesa
No. nonlytic
exocytosis % P valueb
Flow cytometry
No treatment 84,333 20,819 24.7
Baﬁlomycin A1 (100 nM) 28,017 6,294 22.5 0.0001
Chloroquine (10 M) 126,100 60,688 48.1 0.0001
NH4Cl (20 mM) 78,794 23,147 29.4 0.0001
Time-lapse microscopy
No treatment 477 60 12.6
NH4Cl (20 mM) 547 87 15.9 0.1542
a Flow cytometry assays were performed twice, and microscopy experiments were
performed three times on different days. The results from all replicates were pooled.
b P values were calculated using the chi-square test with the Yates correction.
TABLE 2 Comparison of in vitro and in vivo nonlytic exocytosis rates
Condition No. of macrophagesa No. nonlytic exocytosis % P valueb
In vitro 52,879 5,049 9.55
In vivo 520 233 44.83 0.0001
a C. neoformans-containing BMM were intratracheally injected into mice and collected
24 h later for nonlytic exocytosis measurements by ﬂow cytometry. Results from two
independent experiments performed on different days were pooled.
b P values were calculated using the chi-square test with Yates correction.
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cells has relied on laborious and subjective microscopy methods.
These experiments typically allow observation of 100 to 200
phagocytes during a single experimental condition over 24 h, fol-
lowed by time-consuming individual analysis of each individual
cell imaged. Using the new ﬂow cytometric method described in
this study, we routinely tested four individual samples and mea-
sured nonlytic exocytosis in tens of thousands of cells in the same
period of time. The results obtained were generally within the
rangeofpreviousreports,whichwentfromaslowas3.3%tomore
than 60% exocytosis (14, 15, 25). Comparing microscopy and
ﬂow cytometry experiments done under approximately the same
conditions, however, suggests that ﬂow cytometry tends to over-
estimate nonlytic exocytosis rates when using immortal cell lines.
Thisislikelybecauseoverthe24-hincubationperiod,someofthe
phagocytes will undergo type I cell division (26), resulting in live
host cells with no internalized C. neoformans that are not counted
as having exocytosed by microscopy but are not eliminated by
ﬂowcytometry.Gatingonlyonmacrophagesthathavenotunder-
gone replication based on DDAO-SE dilution can eliminate con-
fusion with type I division but will also ignore the frequent
postreplicationnonlyticexocytosisevents(26).Togetherwiththe
fact that type I replication is about eight times less frequent than
nonlytic exocytosis (14, 26) our results show that although the
ﬂow cytometric assay tends to slightly overestimate nonlytic exo-
cytosis rates, it still provides reliable data. Finally, this may not be
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The reader should refer to Fig. S7, which includes a schematic diagram of the experiment detailing the various steps and provides cartoons to assist in the
interpretation of these ﬂow cytometry data.
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ceed through mitosis much less frequently than do J774 cells (27)
andhadlowerratesofextrusioninourexperiments.Ontheother
hand, the ﬂow cytometry method will underestimate the nonlytic
exocytosisratebecauseinsomeexocytosiseventsonlyaportionof
the C. neoformans cell cargo will exit the phagocyte. Because the
method takes into consideration only those phagocytes that are
completely empty of yeast cells, these incomplete exocytosis
events are not counted. Despite these caveats, the ﬂow cytometric
method described here generated results in close agreement with
those previously reported by microscopic analysis: Ma et al. re-
ported that chloroquine increased nonlytic exocytosis from 9.7%
to 20.6% and that concanamycin A, a structural analog of baﬁlo-
mycinA1withthesameactivity,decreasedthenonlyticexocytosis
rate from 9.7% to 3.3% (15). Additionally, we detected an almost
50% decrease in nonlytic exocytosis of heat-killed C. neoformans;
in comparison, Alvarez and Casadevall (14) reported an approxi-
mately80%decrease,whereasMaetal.(15)reportedabolishment
ofnonlyticexocytosiswithdeadC.neoformans.Anotherbeneﬁtof
using ﬂow cytometry is that the difference between untreated and
treated groups was often highly statistically signiﬁcant because of
thelargenumberofcellsstudied.Incontrast,whenweusedtime-
lapse microscopy to compare untreated with ammonium
chloride-treated J774 cells, a difference was observed, but it was
not signiﬁcant. This was also the case with concanamycin
A-treated J774 cells analyzed via microscopy (15).
WeinitiallyhypothesizedthatC.neoformansnonlyticexocyto-
sis was inﬂuenced by phagosomal pH because other pathogens
such as Listeria monocytogenes (28), adenovirus serotype 7 (29),
and Francisella tularensis (30) depend on acidiﬁcation for their
escape from the phagosome. However, the previously described
effectsofconcanamycinAandchloroquineonnonlyticexocytosis
(15), together with the results presented in this work, suggest that
the role of phagosomal acidiﬁcation on C. neoformans nonlytic
exocytosis is not as straightforward. We observed statistically sig-
niﬁcant changes in the rate of nonlytic exocytosis with all treat-
ments that altered phagosomal pH, but the effect of baﬁlomycin
A1 was the opposite from that of the weak bases, and we are un-
certain whether this is physiologically signiﬁcant given the small
magnitude of the measured difference. Since all three drugs cause
phagosomal neutralization, it is possible that the observed differ-
ences result from other effects on cellular function that are pH
independent.
A ﬁrst possible explanation for these results is based on their
mechanisms of action. Baﬁlomycin A1 and concanamycin A in-
hibit the function of vacuolar-type ATPases (31), which acidify
the phagosome by pumping protons into those compartments.
However, macrophages also have V-ATPases that could be inhib-
ited by baﬁlomycin A1 in other compartments, such as the cyto-
plasmic membrane and the Golgi complex (31). Alternatively,
chloroquine and ammonium chloride are weak bases with tro-
pism to acidic organelles that accumulate to high concentrations
in these organelles by ion trapping, leading not only to pH neu-
tralization but also to an increase in osmolarity, which may itself
affect exocytosis. It is possible that any of these pH-independent
effects explain the opposing results on nonlytic exocytosis
Asecondpossibleexplanationforourdisparateresultswiththe
variousphagosomalpHinhibitorsisbasedonthepotentialeffects
ofthesedrugsonC.neoformansandtheirdosedependence.Inthis
study, we treated the cells with baﬁlomycin A1 (100 nM), chloro-
quine (10 M), and ammonium chloride (20 mM). Chloroquine
hasdirecteffectsonC.neoformansinvitroandduringexperimen-
tal cryptococcosis (32). Intracerebral injection of mice with chlo-
roquineandinfectionofmicroglialcellsinvitrowithchloroquine,
ammonium chloride or baﬁlomycin A1 revealed that in the pres-
ence of any of these drugs, both cells and mice had increased
resistance to C. neoformans (33). The concentrations of chloro-
quine and ammonium chloride reported in that publication were
thesameasthoseusedinourstudy;however,baﬁlomycinA1had
the same effect only at 300 nM. Another study revealed similar
effects of chloroquine and ammonium chloride using BMM and
intravenous injection in mice (34). Harrison et al. studied the
antifungal effect of each of these drugs on puriﬁed C. neoformans
cultures(35)andfoundthatchloroquinewasfungicidalat30M,
ammonium chloride at 100 mM, and baﬁlomycin A1 at 250 nM,
butagainatconcentrationsdifferentfromthoseusedinthisstudy.
These examples show that all three drugs that we tested have spe-
ciﬁc effects on C. neoformans, albeit with higher concentrations
than the ones we used. However, as a result of ion trapping, the
concentrationoftheweakamineswithinthephagosomebecomes
even higher; thus, it is feasible that they have opposing effects on
extrusion because of that dose-dependent toxicity to the C. neo-
formans cell.
Theﬁnalpossibleexplanationfortheopposingresultswiththe
neutralizing substances is that they have different effects on the
production and release of macrophage cytokines in response to
C. neoformans. Chloroquine treatment of human peripheral
blood monocytic cells decreased their secretion of the proinﬂam-
matory cytokines tumor necrosis factor alpha (TNF-),
interleukin-1 (IL-1), and IL-6 in response to lipopolysaccha-
ride (LPS) (36) secondary to inhibition of an ERK1/2-MEK1/2
signal transduction pathway (37). As this effect was not observed
after baﬁlomycin A1 treatment (36) and cytokines are known to
interferewithnonlyticexocytosisrates(25),theycouldcontribute
to the explanation for the results that we observed.
In the development of these methods, it became apparent that
they could be adapted to measure the occurrence of nonlytic exo-
cytosis in vivo, during experimental cryptococcosis. One million
live primary macrophages with internalized C. neoformans were
sortedandinjectedintoarecipientmouseinparalleltoastandard
in vitro assay. A major difference between the in vivo and the in
vitro ﬂow cytometric assays is that only approximately 1 in 1,000
of the sorted cells were eventually analyzed after 24 h in vivo.
However, the very small fraction of cells that are eventually ana-
lyzed in vivo is similar to what is achieved using microscopy in
vitro, as in the later experiments only 100 to 200 of 100,000 mac-
rophages in each plate are observed. Several factors could explain
the unexpectedly high loss on the in vivo ﬂow cytometric assay.
Many cells are lost during injection and recovery by bronchoal-
veolar lavage. Additionally, as target cells are far less abundant
than those of the recipient mouse, their detection might be
maskedbytheunlabeledcellsintheﬂowcytometer.Incontrastto
the previous technical factors, it is also possible that the injected
macrophages migrated into the interstitium or outside the lungs
via lymphatic or blood vessels, as has been proposed to occur in
extrapulmonary dissemination of cryptococcosis (9). In spite of
the losses, our results indicate a considerable number of nonlytic
exocytosis events in vivo, with the phenomenon occurring at
much higher rates than those measured during in vitro experi-
ments. The demonstration of nonlytic exocytosis in vivo has pro-
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invasion (38). Furthermore, this approach could conceivably be
exploited for studies of extrapulmonary dissemination.
In summary, we report the development of a new method for
studying nonlytic exocytosis and use it to demonstrate that the
phenomenon occurs in vivo. The enhanced ﬂow cytometric
phagocytosis and nonlytic exocytosis assays described here repre-
sentmajorimprovementsoverpreviousmethods,enablinglonger
incubation periods, increased throughput, better statistical reli-
ability, and easy adaptation to other phagocytes and fungi. These
featurescouldallowinvestigatorstomoreeasilydissectthemech-
anisms responsible for the intriguing phenomenon of nonlytic
exocytosis and perhaps elucidate its importance in the pathogen-
esisofcryptococcosis.Forexample,thesetechniquesmakeitpos-
sibletoascertainthecontributionofhostimmunemechanismsto
thephenomenonofnonlyticexocytosis.Furthermore,thegeneral
nature of the methods used here should allow them to be easily
modiﬁed for use in other phagocyte-pathogen systems.
MATERIALS AND METHODS
Dyes and drugs. CellTracker Green CMFDA (Invitrogen Corporation,
Carlsbad, CA), CellTrace Far Red DDAO-SE (Invitrogen), and 7-AAD
(AnaSpecInc.,Fremont,CA)weredilutedinanhydrousdimethylsulfox-
ide (DMSO). Uvitex 2B (Polysciences Inc., Warrington, PA) was dis-
solved in phosphate-buffered saline (PBS). See additional details about
these ﬂuorescent probes in Table S1 in the supplemental material. Chlo-
roquine, baﬁlomycin A1, and ammonium chloride were purchased from
Sigma (St. Louis, MO).
Cultures and staining. C. neoformans strains B3501 (ATCC 34873)
and H99 (obtained from Mauricio del Poeta, Charleston, SC) and the
acapsular mutant CAP67 were grown in Sabouraud dextrose broth at
30°C with agitation. Cells were washed with PBS and loaded with 2 M
CMFDA in PBS at 37°C for 30 min. Murine macrophage-like J774 cells
(ATCC TIB-67) were maintained at 37°C with 10% CO2 in feeding me-
dium, composed of Dulbecco modiﬁed Eagle medium (DMEM; Life
Technologies, Rockville, MD) that was supplemented with 10% heat-
inactivated fetal calf serum (FCS) (Atlanta Biologicals, Lawrenceville,
GA), 1 nonessential amino acids (Mediatech, Herndon, VA), 10%
NCTC-109 medium (Life Technologies), 50 U/ml penicillin, and
50g/mlstreptomycin.Cellsweremadeadherenttotissueculturedishes
and stained with 1 M DDAO-SE in PBS for 10 min.
Mice. BALB/c mice were obtained from the National Cancer Institute
and used at 6 to 8 weeks of age. BMM were prepared as described in
reference 39. Differentiated macrophages were stained as described for
J774 cells above. For intratracheal infection, mice were anesthetized with
100 mg ketamine/g body weight plus 10 mg xylazine/g body weight fol-
lowedbyinjectionintothedissectedtrachea.Forbronchoalveolarlavage,
thetracheaofCO2-euthanizedmicewascannulatedwitha16-gaugecath-
eter, through which 10 washes with 1 ml each of PBS plus 1 mM EDTA
were made. After red blood cell lysis, the resulting cells were centrifuged
and analyzed as described below. Experiments with mice in this study
were carried out in strict observance of Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC) and National Insti-
tutes of Health (NIH) guidelines. All experiments were approved by the
Albert Einstein College of Medicine Institute of Animal Care and Use
Committee (IACUC) with assurance no. A3312-01 from the Ofﬁce of
LaboratoryAnimalWelfare(OLAW).Allmeasuresweretakentodecrease
suffering.
Phagocytosis. Labeled J774 cells were added to 24-well tissue culture
dishes in feeding medium. CMFDA-labeled C. neoformans cells were op-
sonized with 10 g/ml of the anticapsular IgG1 monoclonal antibody
(MAb) 18B7 and added at a 1:1 effector-to-target cell ratio. Samples were
collected from individual wells at different time points ranging from 1 to
24 h and analyzed by ﬂow cytometry.
Flow cytometry. Harvested cells were analyzed using three different
ﬂow cytometers from BD Biosciences: FACSCalibur, equipped with 488-
and 633-nm lasers; LSRII, equipped with 350-, 407-, 488-, and 633-nm
lasers; and FACSAria, equipped with 405-, 488-, 532-, 561-, and 638-nm
lasersandaerosolcontainmentforbiohazardsorting.Datawerecollected
using CellQuest or FACSDiva and analyzed ofﬂine using FlowJo software
(TreeStar Inc., Ashland, OR). To determine the thresholds above which
events were considered positive, single-color controls were compared
with unstained cells. For nonlytic exocytosis experiments, 30,000 events
were collected using the FACSAria sorter for online compensation (see
Fig. S8 in the supplemental material) and setting of gates (Fig. S9). Mac-
rophages with internalized C. neoformans were aseptically sorted, and
2,000eventsfromthesortedcellsuspensionwereimmediatelycollectedto
determine postsort purity. The remaining cells were incubated as de-
scribed below. All three analyses (presort, postsort, and after 24 h of in-
cubation) were done using the same equipment with identical settings.
Quantiﬁcation of nonlytic exocytosis. To quantify the rates of non-
lyticexocytosisinvitro,macrophageswerelabeledwithDDAO-SEinpetri
dishesandinfectedwithCMFDA-labeledC.neoformansatamacrophage-
to-fungusratioof1:10inthepresenceof50g/mlMAb18B7for2h.Cells
were then stained for 1 min with 0.01% Uvitex 2B in PBS and washed
twice with PBS before the cells were removed with Cellstripper (Mediat-
ech, Manassas, VA) and 1 g/ml 7-AAD was added. A total of 120,000
macrophages with internalized C. neoformans were aseptically sorted as
described above, added to 6-well tissue culture plates with feeding me-
dium, and incubated for 24 h at 37°C with 10% CO2 before being har-
vested, stained with 7-AAD, and again analyzed. For experiments testing
the effects of neutralizing drugs on nonlytic exocytosis, J774 cells were
pretreated with chloroquine (10 M), baﬁlomycin A1 (100 nM), or
NH4Cl (20 mM) for 30 min before phagocytosis; the drugs were also
present during both the 2-h incubation to permit phagocytosis and the
24-h incubation postsorting. For in vivo nonlytic exocytosis experiments,
BMM were stained and infected as described for the in vitro experiments.
A total of 1,000,000 macrophages with internalized C. neoformans were
sorted, centrifuged, and resuspended in 50 l of PBS and then injected
intratracheally as described above. After 24 h, the cells were recovered
along with unlabeled cells from the recipient mouse by bronchoalveolar
lavage as described above and analyzed to determine nonlytic exocytosis
rates.
Time-lapse microscopy. A total of 6  104 J774 cells were made ad-
herent to a glass-bottom MatTek dish (Ashland, MA) and infected with
C. neoformans at a macrophage-to-fungus ratio of 10:1 with 2 g MAb
18B7. When necessary, cells were treated with NH4Cl as described above.
After2hofincubationat37°C,wellswerewashedtoremovenoningested
C. neoformans. Time-lapse pictures were taken with a 10 A-Plan 0.25
phase-contrast objective every 4 min over a 24-h period using a Zeiss
Axiovert200MinvertedmicroscopeandaHamamatsuORCAERcooled
charge-coupled device (CCD) camera. Cells were contained within a mi-
croscopy chamber maintained at 37°C with 5% CO2 during the 24-h
period. Images were collected and analyzed using Zeiss AxioVision soft-
ware.
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